ASTCT News
Published on February 17, 2025
The Latest in ASTCT Advocacy: February 2025
by ASTCT Advocacy Update
Save the Date: ASTCT Government Relations Tandem Spotlight Session and Update in Admin Director Track
Join us for ASTCT's Government Relations Spotlight Session titled "Inside the Administration - Insight into the Federal Government and How We Can Make a Lasting Impact" at the 2025 Tandem Meetings of ASTCT and CIBMTR in Honolulu, Hawaii.
This 90-minute session will take place on Friday, February 14, from 1:45 – 3:15 pm HST and will feature a panel discussion on the best ways to become an effective advocate at the federal level. Click here to learn more about the session.
In addition to the Government Relations Spotlight session, ASTCT Director of Government Relations, Alycia Maloney, will give an update on the latest in advocacy as part of the Adminstrative Director Track, Friday, February 14 from 8:50 AM – 09:20 AM HST. Click here to learn more.
New 2025 Standardized Payer Request for Information (RFI) Forms Now Available
The ASTCT Committee on Payer Relations has updated its standardized Request for Information (RFI) forms for 2025. Reviewed by leading health insurance companies and managed care organizations, these resources are designed to streamline coding and reimbursement processes. Access the latest versions below.
View Updated RFI Forms.
Updated CAR-T Therapy Coding and Billing Guide
ASTCT’s Chimeric Antigen Receptor T-cell (CAR-T) Therapy Coding and Billing Guide has been updated to reflect the latest information for providers. This essential resource helps hospitals and providers navigate appropriate coding and billing for both inpatient and outpatient CAR-T therapy, covering FDA-approved products, clinical trial considerations, and key differences between government and private payers.
View the Updated Guide.
ASTCT Engages CMS on Coverage Issues Impacting Stem Cell Transplants
ASTCT Government Relations committee members met with the CMS coverage team on February 6 to request technical corrections to guidance documents that may be causing inadvertent denials for some MDS or cord blood stem cell transplant cases. CMS confirmed the issues were made in error and is planning to release correction and claims reprocessing information in an upcoming communications cycle, estimated to be sometime between April and July. ASTCT will continue monitoring for this information and circulate it once available.
ASTCT continues to closely monitor legislative developments and advocate for policies that prioritize patient access and NIH funding for research.
![]()